Operating cash flow / net income decreased 42.3%
Operating cash flow / net income changed -42.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow / net income changed -42.3% from the comparable as-filed period.
Cash / debt changed +444 basis points from the comparable as-filed period.
Free-cash-flow proxy changed -13.2% from the comparable as-filed period.
Working capital / assets changed +245 basis points from the comparable as-filed period.
Cash & equivalents changed +18.4% from the comparable as-filed period.
Shares outstanding changed -0.1% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes. This reverses 8 consecutive comparable moves in the opposite direction.
Operating cash flow changed -7.3% from the comparable as-filed period.
Current ratio changed +11.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Gross profit changed +14.1% from the comparable as-filed period.
Current liabilities changed -5.2% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +11.2% from the comparable as-filed period.
Working capital changed +10.9% from the comparable as-filed period.
Debt / assets changed -138 basis points from the comparable as-filed period.
Total assets changed -1.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net debt changed -10.0% from the comparable as-filed period.
Current assets changed +5.3% from the comparable as-filed period.
Cost of revenue changed +1.9% from the comparable as-filed period.
Trade receivables changed +1.2% from the comparable as-filed period.
Reported total debt changed -4.9% from the comparable as-filed period.
Noncurrent long-term debt changed -4.9% from the comparable as-filed period.
Gross debt changed -4.9% from the comparable as-filed period.
Inventory changed +5.1% from the comparable as-filed period.
Capital expenditure changed +2.2% from the comparable as-filed period.
Net income changed +206.1% from the comparable as-filed period.
Cash / debt changed +298 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed +23.1% from the comparable as-filed period.
Research & development changed -64.1% from the comparable as-filed period.
Debt / assets changed -630 basis points from the comparable as-filed period.
Operating cash flow / net income changed -59.8% from the comparable as-filed period.
Net debt changed -21.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Noncurrent long-term debt changed -18.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross debt changed -18.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Reported total debt changed -18.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed +0.4% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
Current liabilities changed +10.7% from the comparable as-filed period.
Cash & equivalents changed -5.5% from the comparable as-filed period.
Current ratio changed -10.5% from the comparable as-filed period.
Working capital / assets changed -88 basis points from the comparable as-filed period.
Inventory changed +8.0% from the comparable as-filed period.
Gross profit changed +11.5% from the comparable as-filed period.
Total assets changed -1.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current assets changed -0.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Trade receivables changed +5.8% from the comparable as-filed period.
Working capital changed -5.7% from the comparable as-filed period.
Capital expenditure changed -7.9% from the comparable as-filed period.
Cost of revenue changed +5.8% from the comparable as-filed period.
Selling, general & administrative changed +0.8% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.